Anebulo Pharmaceuticals ANEB Stock
1.12 USD
{{ price }}
0.900900%
{{change_pct}}%
SECTOR
Healthcare
INDUSTRY
Biotechnology
COUNTRY
United States
Exchange
NasdaqCM
Market Cap
46.01M USD
LOW - HIGH [24H]
1.09
-
1.12 USD
VOLUME [24H]
4.28K USD
{{ volume }}
P/E Ratio
0
Earnings per share
-0.25 USD
Anebulo Pharmaceuticals Price Chart
Anebulo Pharmaceuticals ANEB Financial and Trading Overview
| Anebulo Pharmaceuticals stock price | 1.12 USD |
| Previous Close | 2.14 USD |
| Open | 2.15 USD |
| Bid | 0 USD x 1000 |
| Ask | 0 USD x 1200 |
| Day's Range | 2.15 - 2.4 USD |
| 52 Week Range | 1.77 - 7 USD |
| Volume | 996 USD |
| Avg. Volume | 3.47K USD |
| Market Cap | 61.52M USD |
| Beta (5Y Monthly) | -1.430985 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.25 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 7 USD |
ANEB Valuation Measures
| Enterprise Value | 47.35M USD |
| Trailing P/E | N/A |
| Forward P/E | -4.5281134 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 4.7522774 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Anebulo Pharmaceuticals Stock Price History
| Beta (5Y Monthly) | -1.430985 |
| 52-Week Change | -11.43% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 7 USD |
| 52 Week Low | 1.77 USD |
| 50-Day Moving Average | 2.54 USD |
| 200-Day Moving Average | 2.75 USD |
ANEB Share Statistics
| Avg. Volume (3 month) | 3.47K USD |
| Avg. Daily Volume (10-Days) | 2.86K USD |
| Shares Outstanding | 25.63M |
| Float | 2.93M |
| Short Ratio | 0.12 |
| % Held by Insiders | 69.00% |
| % Held by Institutions | 27.54% |
| Shares Short | 386 |
| Short % of Float | 0.010% |
| Short % of Shares Outstanding | 0% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | June 30, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | June 30, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -45.82% |
| Return on Equity (ttm) | -76.79% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | -11559500 USD |
| Diluted EPS (ttm) | -0.48 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 14.16M USD |
| Total Cash Per Share (mrq) | 0.55 USD |
| Total Debt (mrq) | 0 USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 9.679 |
| Book Value Per Share (mrq) | 0.505 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -8833143 USD |
| Levered Free Cash Flow (ttm) | -4532827 USD |
Profile of Anebulo Pharmaceuticals
| Country | United States |
| State | TX |
| City | Lakeway |
| Address | 1415 Ranch Road 620 South |
| ZIP | 78734 |
| Phone | 512-598-0931 |
| Website | https://www.anebulo.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 4 |
Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing solutions for people suffering from acute cannabinoid intoxication (ACI) and substance addiction. Its lead product candidate is ANEB-001, a small molecule cannabinoid receptor antagonist, which is in a Phase II clinical trial to address the unmet medical need for a specific antidote for ACI. The company was incorporated in 2020 and is based in Lakeway, Texas.
Q&A For Anebulo Pharmaceuticals Stock
What is a current ANEB stock price?
Anebulo Pharmaceuticals ANEB stock price today per share is 1.12 USD.
How to purchase Anebulo Pharmaceuticals stock?
You can buy ANEB shares on the NasdaqCM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Anebulo Pharmaceuticals?
The stock symbol or ticker of Anebulo Pharmaceuticals is ANEB.
Which industry does the Anebulo Pharmaceuticals company belong to?
The Anebulo Pharmaceuticals industry is Biotechnology.
How many shares does Anebulo Pharmaceuticals have in circulation?
The max supply of Anebulo Pharmaceuticals shares is 41.08M.
What is Anebulo Pharmaceuticals Price to Earnings Ratio (PE Ratio)?
Anebulo Pharmaceuticals PE Ratio is now.
What was Anebulo Pharmaceuticals earnings per share over the trailing 12 months (TTM)?
Anebulo Pharmaceuticals EPS is -0.25 USD over the trailing 12 months.
Which sector does the Anebulo Pharmaceuticals company belong to?
The Anebulo Pharmaceuticals sector is Healthcare.
Anebulo Pharmaceuticals ANEB included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 18737.21 USD — |
-1
|
7.88B USD — | 18599.69 USD — | 18841.52 USD — | — - | 7.88B USD — |
| Nasdaq Health Care IXHC | 932.02 USD — |
-0.03
|
— — | 920.46 USD — | 933.54 USD — | — - | — — |
- {{ link.label }} {{link}}